Abstract:Background: Obstructive severe acute biliary pancreatitis (SABP) is a clinical emergency with a high rate of mortality that can be alleviated by endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangial drainage (PTCD) selectively. However, the optimal timing of ERCP and PTCD requires elucidation. Aim: The aim of this study was to evaluate outcome parameters in patients with SABP subjected to ERCP and PTCD compared to SABP patients who were not subjected to any form of invasive intervention. Methods: A total of 62 patients with obstructive SABP who had been treated from July 2013 to July 2019 were included in this retrospective case-control study and stratified into a PTCD group (N = 22), ERCP group (N = 24), and conservative treatment group (N = 16, control). Patients in the PTCD and ERCP groups were substratified into early (≤72 h) and delayed (>72 h) treatment groups based on the timing of the intervention after diagnosis. Clinical chemistry, hospitalization days, liver function, abdominal pain, and complications were determined to assess the treatment efficacy and safety of each modality and to establish the optimal timing for PTCD and ERCP. Results: The average hospitalization time, time to abdominal pain relief, and time to normalization of hematological and clinical chemistry parameters (leukocyte count, amylase, alanine transaminase [ALT], and total bilirubin [TBiL]) were shorter in the PTCD and ERCP groups compared to the conservative treatment group (p < 0.05). The average hospitalization time in the ERCP group (16.7 ± 4.0 d) was shorter compared to the PTCD group (19.6 ± 4.3 d) (p < 0.05). Compared to the conservative treatment group (62.5%), there were more complications in patients treated with ERCP and PTCD (p < 0.05). In the early ERCP group, the average hospitalization time (13.9 ± 3.3 d) and the time to normalization of leukocyte count (6.3 ± 0.9 d) and TBiL (9.1 ± 2.0 d) were lower than in the delayed ERCP group (18.6 ± 4.1 d, 9.9 ± 2.4 d, 11.8 ± 2.9 d, respectively) and early PTCD group (16.4 ± 3.7 d, 8.5 ± 2.1 d, 10.9 ± 3.1 d, respectively) (p < 0.05). In the delayed ERCP group, the average hospitalization time (18.6 ± 4.1 d) and ALT recovery time (12.2 ± 2.6 d) were lower than in the delayed PTCD group (21.9 ± 4.3 d and 14.9 ± 3.9 d, respectively) (p < 0.05). Conclusions: ERCP and PTCD effectively relieve SABP-associated biliary obstruction with comparable overall incidence of complications. It is recommended that ERCP is performed within 72 h after diagnosis; and PTCD drainage may be considered an alternative approach in cases where patients are unable or unwilling to undergo ERCP, or when ERCP is unsuccessful. Relevance for patients: ERCP and PTCD in patients with obstructive SABP can resolve biliary obstruction and delay progression of the disease. Performing ERCP and PTCD within 72 h (i.e., optimal treatment time window) can be beneficial to patients, especially in terms of post-operative recovery. Visual biliary endoscopy (oral or percutaneous transhepatic) may be used for concomitant therapeutic interventions in the biliary system.

S2603 Acute Cholangitis and Endoscopic Interventions: The Need to Tailor Our Treatment Approach

Evaluation of Clinical Indications of Three Treatments for Choledocholithiasis with Acute Cholangitis

Urgent one-stage endoscopic treatment for choledocholithiasis related moderate to severe acute cholangitis: A propensity score-matched analysis

S1612 Endoscopic Ultrasound-Guided Biliary Drainage for Acute Cholangitis Secondary to Biliary Obstruction: A Systematic Review and Meta-Analysis

Optimal Timing of Cholecystectomy for Patients with Concurrent Acute Cholecystitis and Acute Cholangitis after Successful Biliary Drainage by Interventional Endoscopic Retrograde Cholangiopancreatography

An elusive case of endoscopic retrograde cholangiopancreatography: a case report

Approaches to Cholecystitis: Surgical, Endoscopic, and Percutaneous Management

Part 2: Current Concepts in Radiologic Imaging & Intervention in Acute Biliary Tract Diseases

Current status of endoscopic management of cholecystitis

269 Endosonography-Guided Gallbladder Drainage Versus Percutaneous Cholecystostomy As a Definitive Management for Acute Cholecystitis in Patients That Are Unfit for Surgery

Endoscopic retrograde cholangiopancreatography: Current practice and future research

A unusual case of multifocal pyogenic abscess formation following ERCP procedure

S1553 Therapeutic Endoscopic Retrograde Cholangiopancreatography in Patients With Cirrhosis: A 5-year Nationwide Analysis of Sociodemographic Characteristics and Inpatient Outcomes

Acute cholangitis: a state-of-the-art review

Impact of timing of ERCP on long term outcomes of ERCP for acute cholangitis - A single center retrospective study

Post-cholecystectomy iatrogenic bile duct injuries: Emerging role for endoscopic management

S103 A Nationwide Comparison of the Outcomes of Endoscopic Versus Percutaneous Gallbladder Drainage in the Management of Acute Cholecystitis

Therapeutic outcomes of early and delayed endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangial drainage in patients with obstructive severe acute biliary pancreatitis

Endoscopic ultrasonography guided drainage: Summary of consortium meeting, May 21, 2012, San Diego, California

Periendoscopic Care Continuum in Acute Cholangitis Caused By Common Bile Duct Stone

S4041 Single-Session EUS-Directed Transgastric ERCP and Simultaneous EUS-Guided Transmural Gallbladder Drainage in a Choledocholithiasis and Acute Cholecystitis Patient After Unsuccessful Laparoscopic Cholecystectomy